ICUI vs. MMSI, HAE, XRAY, QDEL, NEOG, STAA, CERS, OSUR, UTMD, and ANIK
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Merit Medical Systems (MMSI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry.
ICU Medical vs. Its Competitors
ICU Medical (NASDAQ:ICUI) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.
Merit Medical Systems has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
In the previous week, Merit Medical Systems had 5 more articles in the media than ICU Medical. MarketBeat recorded 7 mentions for Merit Medical Systems and 2 mentions for ICU Medical. Merit Medical Systems' average media sentiment score of 0.82 beat ICU Medical's score of 0.77 indicating that Merit Medical Systems is being referred to more favorably in the news media.
ICU Medical has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.5% of ICU Medical shares are held by insiders. Comparatively, 3.2% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Merit Medical Systems has a net margin of 8.81% compared to ICU Medical's net margin of -3.87%. Merit Medical Systems' return on equity of 15.52% beat ICU Medical's return on equity.
ICU Medical presently has a consensus price target of $192.67, suggesting a potential upside of 42.19%. Merit Medical Systems has a consensus price target of $109.11, suggesting a potential upside of 16.63%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts plainly believe ICU Medical is more favorable than Merit Medical Systems.
Summary
Merit Medical Systems beats ICU Medical on 12 of the 17 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICU Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICUI) was last updated on 7/5/2025 by MarketBeat.com Staff